|
1. Siegel, R., D. Naishadham, and A. Jemal, Cancer statistics, 2012. CA Cancer J Clin, 2012. 62(1): p. 10-29.
2. Wahbah, M., et al., Changing trends in the distribution of the histologic types of lung cancer: a review of 4,439 cases. Ann Diagn Pathol, 2007. 11(2): p. 89-96.
3. Groome, P.A., et al., The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol, 2007. 2(8): p. 694-705.
4. Mountain, C.F., The evolution of the surgical treatment of lung cancer. Chest Surg Clin N Am, 2000. 10(1): p. 83-104.
5. Mountain, C.F., Staging classification of lung cancer. A critical evaluation. Clin Chest Med, 2002. 23(1): p. 103-21.
6. Ringner, M. and J. Staaf, Consensus of gene expression phenotypes and prognostic risk predictors in primary lung adenocarcinoma. Oncotarget, 2016. 7(33): p. 52957-52973.
7. Chong, C.R. and P.A. Janne, The quest to overcome resistance to EGFR-targeted therapies in cancer. Nat Med, 2013. 19(11): p. 1389-400.
8. Tetsu, O., et al., Drug Resistance to EGFR Inhibitors in Lung Cancer. Chemotherapy, 2016. 61(5): p. 223-35.
9. Lo, H.W., EGFR-targeted therapy in malignant glioma: novel aspects and mechanisms of drug resistance. Curr Mol Pharmacol, 2010. 3(1): p. 37-52.
10. Chan, S.K., W.J. Gullick, and M.E. Hill, Mutations of the epidermal growth factor receptor in non-small cell lung cancer -- search and destroy. Eur J Cancer, 2006. 42(1): p. 17-23.
11. Shigematsu, H. and A.F. Gazdar, Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers. Int J Cancer, 2006. 118(2): p. 257-62.
12. Sharma, S.V., et al., Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer, 2007. 7(3): p. 169-81.
13. Yun, C.H., et al., Structures of lung cancer-derived EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity. Cancer Cell, 2007. 11(3): p. 217-27.
14. Fang, S. and Z. Wang, EGFR mutations as a prognostic and predictive marker in non-small-cell lung cancer. Drug Des Devel Ther, 2014. 8: p. 1595-611.
15. Morgensztern, D., et al., Molecularly targeted therapies in non-small-cell lung cancer annual update 2014. J Thorac Oncol, 2015. 10(1 Suppl 1): p. S1-63.
16. Depeursinge, A., et al., Lung texture classification using locally-oriented Riesz components. Med Image Comput Comput Assist Interv, 2011. 14(Pt 3): p. 231-8.
17. Ganeshan, B., et al., Tumour heterogeneity in oesophageal cancer assessed by CT texture analysis: preliminary evidence of an association with tumour metabolism, stage, and survival. Clin Radiol, 2012. 67(2): p. 157-64.
18. Cunliffe, A.R., et al., Lung texture in serial thoracic CT scans: assessment of change introduced by image registration. Med Phys, 2012. 39(8): p. 4679-90.
19. Mansoor, A., et al., Segmentation and Image Analysis of Abnormal Lungs at CT: Current Approaches, Challenges, and Future Trends. Radiographics, 2015. 35(4): p. 1056-76.
20. El-Baz, A., et al., Computer-aided diagnosis systems for lung cancer: challenges and methodologies. Int J Biomed Imaging, 2013. 2013: p. 942353.
21. Heim, B., et al., Magnetic resonance imaging for the diagnosis of Parkinson's disease. J Neural Transm (Vienna), 2017. 124(8): p. 915-964.
22. Ozkan, E., et al., CT Gray-Level Texture Analysis as a Quantitative Imaging Biomarker of Epidermal Growth Factor Receptor Mutation Status in Adenocarcinoma of the Lung. AJR Am J Roentgenol, 2015. 205(5): p. 1016-25.
23. Hu, W., et al., Characterization of collagen fibers by means of texture analysis of second harmonic generation images using orientation-dependent gray level co-occurrence matrix method. J Biomed Opt, 2012. 17(2): p. 026007.
24. Mahmood, U., et al., Investigating the Robustness Neighborhood Gray Tone Difference Matrix and Gray Level Co-occurrence Matrix Radiomic Features on Clinical Computed Tomography Systems Using Anthropomorphic Phantoms: Evidence From a Multivendor Study. J Comput Assist Tomogr, 2017.
25. Karacavus, S., et al., Can Laws Be a Potential PET Image Texture Analysis Approach for Evaluation of Tumor Heterogeneity and Histopathological Characteristics in NSCLC? J Digit Imaging, 2017.
26. Sogawa, K., et al., Neurogenic and Myogenic Diseases: Quantitative Texture Analysis of Muscle US Data for Differentiation. Radiology, 2017. 283(2): p. 492-498.
27. Ergen, B. and M. Baykara, Texture based feature extraction methods for content based medical image retrieval systems. Biomed Mater Eng, 2014. 24(6): p. 3055-62.
|